Frederic TRIEBEL

Person

Versailles, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Combined preparations for the treatment of cancer
- Patent number 12,214,012
- Issue date Feb 4, 2025
- IMMUTEP S.A.S.
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined preparations for the treatment of cancer or infection
- Patent number 11,684,654
- Issue date Jun 27, 2023
- Immutep S.A.S.
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-LAG-3 antibodies
- Patent number 11,680,104
- Issue date Jun 20, 2023
- Immutep S.A.S.
- Frédéric Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of recombinant LAG-3 or the derivatives thereof for eliciting m...
- Patent number 11,583,582
- Issue date Feb 21, 2023
- IMMUTEP
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined preparations for the treatment of cancer or infection
- Patent number 10,940,181
- Issue date Mar 9, 2021
- Immutep S.A.S.
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined preparations for the treatment of cancer or infection
- Patent number 10,874,713
- Issue date Dec 29, 2020
- Immutep S.A.S.
- Frederic Triebel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combined preparations for the treatment of cancer
- Patent number 10,736,940
- Issue date Aug 11, 2020
- Immutep S.A.S.
- Frederic Triebel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody molecules to LAG-3 and uses thereof
- Patent number 10,711,060
- Issue date Jul 14, 2020
- Novartis AG
- Frédéric Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of recombinant LAG-3 or the derivatives thereof for eliciting m...
- Patent number 10,232,038
- Issue date Mar 19, 2019
- IMMUTEP
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to LAG-3 and uses thereof
- Patent number 9,908,936
- Issue date Mar 6, 2018
- Novartis AG
- Frédéric Triebel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of recombinant LAG-3 or the derivatives thereof for eliciting m...
- Patent number 9,579,382
- Issue date Feb 28, 2017
- IMMUTEP
- Frédéric Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatme...
- Patent number 9,244,059
- Issue date Jan 26, 2016
- Immutep Parc Club Orsay
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide sequence coding for variable regions of β chains of huma...
- Patent number 8,709,426
- Issue date Apr 29, 2014
- Aventis Pharma S.A.
- Thierry Hercend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions containing LAG-3 and cells that secrete GM-CSF and met...
- Patent number 8,425,897
- Issue date Apr 23, 2013
- Immutep S.A.
- Karin Jooss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide sequences coding for variable regions of β chains of hum...
- Patent number 7,294,712
- Issue date Nov 13, 2007
- Aventis Pharma S.A.
- Thierry Hercend
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of MHC class II ligands as adjuvant for vaccination and of LAG-...
- Patent number 7,109,026
- Issue date Sep 19, 2006
- Institut Gustave Roussy
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide compounds derived from a shifted ORF of the iCE gene
- Patent number 6,875,844
- Issue date Apr 5, 2005
- Institut Gustave Roussy
- Christophe Ronsin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mutated peptide compounds, derived from hsp70, useful in cancer imm...
- Patent number 6,855,802
- Issue date Feb 15, 2005
- Institut Gustave Roussy
- Frédéric Triebel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Soluble polypeptide fractions of the LAG-3 protein, production meth...
- Patent number RE38313
- Issue date Nov 11, 2003
- Institut Gustave Roussy
- Florence Faure
- 435 - Chemistry: molecular biology and microbiology
Information Patent Grant
Nucleotide sequences coding for variable regions of the alpha chain...
- Patent number 6,596,536
- Issue date Jul 22, 2003
- Aventis Pharma S.A.
- Thierry Hercend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
- Patent number 6,482,925
- Issue date Nov 19, 2002
- Applied Research Systems ARS Holding N.V.
- Nabil El Tayar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of MHC class II ligands as adjuvant for vaccination and of LAG-...
- Patent number 6,410,509
- Issue date Jun 25, 2002
- Institut Gustave Roussy
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic composition containing antibodies to soluble polypeptid...
- Patent number 6,143,273
- Issue date Nov 7, 2000
- Institut Gustave Roussy
- Florence Faure
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide sequences coding for variable regions of the .alpha.chai...
- Patent number 6,114,516
- Issue date Sep 5, 2000
- Hoechst Marion Roussel
- Thierry Hercend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteins produced by human lymphocytes DNA sequence encoding these...
- Patent number 5,976,877
- Issue date Nov 2, 1999
- Institut National de la Sante et de la Recherche Medicale (Inserm)
- Thierry Hercend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Soluble polypeptide fractions of the LAG-3 protein, production meth...
- Patent number 5,955,300
- Issue date Sep 21, 1999
- Institut Gustave Roussy
- Florence Faure
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding for a protein containing the extracellular domain of l...
- Patent number 5,874,250
- Issue date Feb 23, 1999
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Thierry Hercend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated V.beta. TCR antibodies
- Patent number 5,830,758
- Issue date Nov 3, 1998
- Roussel Uclaf
- Thierry Hercend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide sequence coding for variable regions of the .alpha. chai...
- Patent number 5,817,511
- Issue date Oct 6, 1998
- Roussel Uclaf
- Thierry Hercend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide sequences for .alpha. chain variable regions in human ly...
- Patent number 5,798,231
- Issue date Aug 25, 1998
- Roussel Uclaf
- Thierry Hercend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TRIPLE COMBINATION THERAPY
- Publication number 20240277804
- Publication date Aug 22, 2024
- Immutep S.A.S.
- Frederic TRIEBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION
- Publication number 20230330182
- Publication date Oct 19, 2023
- IMMUTEP S.A.S.
- Frederic TRIEBEL
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
ANTI-LAG-3 ANTIBODIES
- Publication number 20230272107
- Publication date Aug 31, 2023
- IMMUTEP S.A.S.
- Frédéric TRIEBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER
- Publication number 20230210946
- Publication date Jul 6, 2023
- Immutep S.A.S.
- Frederic TRIEBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING M...
- Publication number 20230149541
- Publication date May 18, 2023
- IMMUTEP
- Frederic TRIEBEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION
- Publication number 20230074746
- Publication date Mar 9, 2023
- IMMUTEP S.A.S.
- Frederic TRIEBEL
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
ASSAYS
- Publication number 20220341913
- Publication date Oct 27, 2022
- IMMUTEP S.A.S.
- Frederic TRIEBEL
- G01 - MEASURING TESTING
Information Patent Application
ANTI-LAG-3 BINDING MOLECULES
- Publication number 20220220199
- Publication date Jul 14, 2022
- IMMUTEP S.A.S.
- Frederic TRIEBEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3
- Publication number 20220153835
- Publication date May 19, 2022
- Novartis AG
- Glenn DRANOFF
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...
- Publication number 20210317210
- Publication date Oct 14, 2021
- IMMUTEP
- Thomas HAUDEBOURG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION
- Publication number 20210177937
- Publication date Jun 17, 2021
- IMMUTEP S.A.S.
- Frederic TRIEBEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
- Publication number 20210009687
- Publication date Jan 14, 2021
- Novartis AG
- Frédéric Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER
- Publication number 20200323957
- Publication date Oct 15, 2020
- IMMUTEP S.A.S.
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION
- Publication number 20200121757
- Publication date Apr 23, 2020
- IMMUTEP S.A.S.
- Frederic TRIEBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING M...
- Publication number 20190175726
- Publication date Jun 13, 2019
- IMMUTEP
- Frederic TRIEBEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-LAG-3 ANTIBODIES
- Publication number 20190153112
- Publication date May 23, 2019
- IMMUTEP S.A.S.
- Frédéric TRIEBEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...
- Publication number 20190135916
- Publication date May 9, 2019
- IMMUTEP
- Thomas HAUDEBOURG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3
- Publication number 20180340025
- Publication date Nov 29, 2018
- Novartis AG
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION
- Publication number 20180271940
- Publication date Sep 27, 2018
- IMMUTEP S.A.S.
- Frederic TRIEBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
- Publication number 20180086830
- Publication date Mar 29, 2018
- Novartis AG
- Frédéric Triebel
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
- Publication number 20170210804
- Publication date Jul 27, 2017
- Novartis AG
- Frédéric Triebel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING M...
- Publication number 20170119876
- Publication date May 4, 2017
- IMMUTEP
- Frederic TRIEBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER
- Publication number 20160310570
- Publication date Oct 27, 2016
- IMMUTEP S.A.S.
- Frederic TRIEBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...
- Publication number 20160176965
- Publication date Jun 23, 2016
- IMMUTEP PARC CLUB ORSAY
- Thomas Haudebourg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
- Publication number 20150259420
- Publication date Sep 17, 2015
- Novartis AG
- Frédéric Triebel
- G01 - MEASURING TESTING
Information Patent Application
CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...
- Publication number 20110070238
- Publication date Mar 24, 2011
- IMMUTEP PARC CLUB ORSAY
- FREDERIC TRIEBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING M...
- Publication number 20110008331
- Publication date Jan 13, 2011
- IMMUTEP
- Frédéric Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...
- Publication number 20100233183
- Publication date Sep 16, 2010
- Frederic Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APC ACTIVATORS IN COMBINATION WITH A CYTOKINE-SECRETING CELL AND ME...
- Publication number 20090130054
- Publication date May 21, 2009
- Cell Genesys, Inc.
- Karin Jooss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEOTIDE SEQUENCE CODING FOR VARIABLE REGIONS OF BETA CHAINS OF H...
- Publication number 20080069770
- Publication date Mar 20, 2008
- Aventis Pharma S.A.
- Thierry Hercend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Frederic TRIEBEL

Person

Patents Grantslast 30 patents

Combined preparations for the treatment of cancer

Combined preparations for the treatment of cancer or infection

Anti-LAG-3 antibodies

Use of recombinant LAG-3 or the derivatives thereof for eliciting m...

Combined preparations for the treatment of cancer or infection

Combined preparations for the treatment of cancer or infection

Combined preparations for the treatment of cancer

Antibody molecules to LAG-3 and uses thereof

Use of recombinant LAG-3 or the derivatives thereof for eliciting m...

Antibody molecules to LAG-3 and uses thereof

Use of recombinant LAG-3 or the derivatives thereof for eliciting m...

Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatme...

Nucleotide sequence coding for variable regions of β chains of huma...

Compositions containing LAG-3 and cells that secrete GM-CSF and met...

Nucleotide sequences coding for variable regions of β chains of hum...

Use of MHC class II ligands as adjuvant for vaccination and of LAG-...

Peptide compounds derived from a shifted ORF of the iCE gene

Mutated peptide compounds, derived from hsp70, useful in cancer imm...

Soluble polypeptide fractions of the LAG-3 protein, production meth...

Nucleotide sequences coding for variable regions of the alpha chain...

Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants

Use of MHC class II ligands as adjuvant for vaccination and of LAG-...

Therapeutic composition containing antibodies to soluble polypeptid...

Nucleotide sequences coding for variable regions of the .alpha.chai...

Proteins produced by human lymphocytes DNA sequence encoding these...

Soluble polypeptide fractions of the LAG-3 protein, production meth...

DNA encoding for a protein containing the extracellular domain of l...

Isolated V.beta. TCR antibodies

Nucleotide sequence coding for variable regions of the .alpha. chai...

Nucleotide sequences for .alpha. chain variable regions in human ly...

Patents Applicationslast 30 patents

TRIPLE COMBINATION THERAPY

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

ANTI-LAG-3 ANTIBODIES

TREATMENT OF CANCER

USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING M...

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

ASSAYS

ANTI-LAG-3 BINDING MOLECULES

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING M...

ANTI-LAG-3 ANTIBODIES

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING M...

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...

USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING M...

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATME...

APC ACTIVATORS IN COMBINATION WITH A CYTOKINE-SECRETING CELL AND ME...

NUCLEOTIDE SEQUENCE CODING FOR VARIABLE REGIONS OF BETA CHAINS OF H...